These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 17957793

  • 1. Flutamide reduced prostate cancer development and prostate stem cell antigen mRNA expression in high grade prostatic intraepithelial neoplasia.
    Zhigang Z, Wenlu S.
    Int J Cancer; 2008 Feb 15; 122(4):864-70. PubMed ID: 17957793
    [Abstract] [Full Text] [Related]

  • 2. Prostate stem cell antigen (PSCA) mRNA expression in prostatic intraepithelial neoplasia: implications for the development of prostate cancer.
    Zhigang Z, Wenlu S.
    Prostate; 2007 Aug 01; 67(11):1143-51. PubMed ID: 17503471
    [Abstract] [Full Text] [Related]

  • 3. External beam radiotherapy (EBRT) suppressed prostate stem cell antigen (PSCA) mRNA expression in clinically localized prostate cancer.
    Zhigang Z, Wenlu S.
    Prostate; 2007 May 01; 67(6):653-60. PubMed ID: 17342746
    [Abstract] [Full Text] [Related]

  • 4. Prostate stem cell antigen mRNA expression in preoperatively negative biopsy specimens predicts subsequent cancer after transurethral resection of the prostate for benign prostatic hyperplasia.
    Zhao Z, Liu J, Li S, Shen W.
    Prostate; 2009 Sep 01; 69(12):1292-302. PubMed ID: 19462463
    [Abstract] [Full Text] [Related]

  • 5. Complete androgen ablation suppresses prostate stem cell antigen (PSCA) mRNA expression in human prostate carcinoma.
    Zhigang Z, Wenlu S.
    Prostate; 2005 Dec 01; 65(4):299-305. PubMed ID: 16015594
    [Abstract] [Full Text] [Related]

  • 6. Prostate stem cell antigen (PSCA) expression in human prostate cancer tissues: implications for prostate carcinogenesis and progression of prostate cancer.
    Zhigang Z, Wenlv S.
    Jpn J Clin Oncol; 2004 Jul 01; 34(7):414-9. PubMed ID: 15342669
    [Abstract] [Full Text] [Related]

  • 7. Flutamide in men with prostatic intraepithelial neoplasia: a randomized, placebo-controlled chemoprevention trial.
    Alberts SR, Novotny PJ, Sloan JA, Danella J, Bostwick DG, Sebo TJ, Blute ML, Fitch TR, Levitt R, Lieberman R, Loprinzi CL.
    Am J Ther; 2006 Jul 01; 13(4):291-7. PubMed ID: 16858161
    [Abstract] [Full Text] [Related]

  • 8. The association of prostate stem cell antigen (PSCA) mRNA expression and subsequent prostate cancer risk in men with benign prostatic hyperplasia following transurethral resection of the prostate.
    Zhigang Z, Wenlu S.
    Prostate; 2008 Feb 01; 68(2):190-9. PubMed ID: 18076024
    [Abstract] [Full Text] [Related]

  • 9. PSCA mRNA expression in preoperatively negative prostate biopsies predicts incidental prostate cancer in patients undergoing transurethral resection of the prostate for benign prostatic hyperplasia.
    Zhao Z, Ma W, Zeng G, Qi D.
    J Surg Oncol; 2011 Nov 01; 104(6):672-8. PubMed ID: 21674503
    [Abstract] [Full Text] [Related]

  • 10. Immunohistochemical expression of prostate stem cell antigen in cystoprostatectomies with incidental prostate cancer.
    Mazzucchelli R, Barbisan F, Santinelli A, Lopez-Beltran A, Cheng L, Scarpelli M, Montironi R.
    Int J Immunopathol Pharmacol; 2009 Nov 01; 22(3):755-62. PubMed ID: 19822092
    [Abstract] [Full Text] [Related]

  • 11. Prostate cancer diagnosis among men with isolated high-grade intraepithelial neoplasia enrolled onto a 3-year prospective phase III clinical trial of oral toremifene.
    Taneja SS, Morton R, Barnette G, Sieber P, Hancock ML, Steiner M.
    J Clin Oncol; 2013 Feb 10; 31(5):523-9. PubMed ID: 23295793
    [Abstract] [Full Text] [Related]

  • 12. Expression of prostate stem cell antigen (PSCA) in prostate cancer: a tissue microarray study of Iranian patients.
    Taeb J, Asgari M, Abolhasani M, Farajollahi MM, Madjd Z.
    Pathol Res Pract; 2014 Jan 10; 210(1):18-23. PubMed ID: 24183365
    [Abstract] [Full Text] [Related]

  • 13. Prostate stem cell antigen: a cell surface marker overexpressed in prostate cancer.
    Reiter RE, Gu Z, Watabe T, Thomas G, Szigeti K, Davis E, Wahl M, Nisitani S, Yamashiro J, Le Beau MM, Loda M, Witte ON.
    Proc Natl Acad Sci U S A; 1998 Feb 17; 95(4):1735-40. PubMed ID: 9465086
    [Abstract] [Full Text] [Related]

  • 14. Expression of prostate stem cell antigen in high-grade prostatic intraepithelial neoplasia and prostate cancer.
    Barbisan F, Mazzucchelli R, Santinelli A, Scarpelli M, Lopez-Beltran A, Cheng L, Montironi R.
    Histopathology; 2010 Oct 17; 57(4):572-9. PubMed ID: 20955382
    [Abstract] [Full Text] [Related]

  • 15. MicroRNA alteration and putative target genes in high-grade prostatic intraepithelial neoplasia and prostate cancer: STAT3 and ZEB1 are upregulated during prostate carcinogenesis.
    Cha YJ, Lee JH, Han HH, Kim BG, Kang S, Choi YD, Cho NH.
    Prostate; 2016 Jul 17; 76(10):937-47. PubMed ID: 27017949
    [Abstract] [Full Text] [Related]

  • 16. HER2 expression and gene amplification in pT2a Gleason score 6 prostate cancer incidentally detected in cystoprostatectomies: comparison with clinically detected androgen-dependent and androgen-independent cancer.
    Montironi R, Mazzucchelli R, Barbisan F, Stramazzotti D, Santinelli A, Scarpelli M, Lòpez Beltran A.
    Hum Pathol; 2006 Sep 17; 37(9):1137-44. PubMed ID: 16938518
    [Abstract] [Full Text] [Related]

  • 17. Chemoprevention for prostatic carcinoma: The role of flutamide in patients with prostatic intraepithelial neoplasia.
    Alberts SR, Blute ML.
    Urology; 2001 Apr 17; 57(4 Suppl 1):188-90. PubMed ID: 11295624
    [Abstract] [Full Text] [Related]

  • 18. Prostate stem cell antigen (PSCA) expression in human prostate cancer tissues and its potential role in prostate carcinogenesis and progression of prostate cancer.
    Zhigang Z, Wenlv S.
    World J Surg Oncol; 2004 May 10; 2():13. PubMed ID: 15132743
    [Abstract] [Full Text] [Related]

  • 19. Reverse transcriptase-polymerase chain reaction and immunohistochemical studies for detection of prostate stem cell antigen expression in prostate cancer: potential value in molecular staging of prostate cancer.
    Joung JY, Yang SO, Jeong IG, Han KS, Seo HK, Chung J, Park WS, Lee KH.
    Int J Urol; 2007 Jul 10; 14(7):635-43. PubMed ID: 17645609
    [Abstract] [Full Text] [Related]

  • 20. Peripheral blood reverse transcription PCR assay for prostate stem cell antigen correlates with androgen-independent progression in advanced prostate cancer.
    Zhao Z, Zeng G, Ma W, Ou L, Liang Y.
    Int J Cancer; 2012 Aug 15; 131(4):902-10. PubMed ID: 21952944
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.